Humana's Investor Day Summary

Deutsche Bank has published a research report on Humana HUM following the company's Investor Day. In the report, Deutsche Bank writes "Humana's initial 2011 EPS guidance of $5.35-5.55 came in 11% below the Street's estimate of $6.11 and also below our $5.80 forecast. While Humana's guidance assumes that earnings will decline significantly in the core Medicare Advantage business, this outlook appears conservative given that med cost trends have improved since the initial MA bids were submitted earlier in 2010. We are maintaining our estimates and PT." Deutsche Bank maintains its Hold rating and $56 price target. Humana closed yesterday at $56.81.